Search

Jeffrey T. Palenik

Examiner (ID: 8947, Phone: (571)270-1966 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
1192
Issued Applications
644
Pending Applications
99
Abandoned Applications
467

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19297694 [patent_doc_number] => 20240226260 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2024-07-11 [patent_title] => VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/277150 [patent_app_country] => US [patent_app_date] => 2022-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277150 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/277150
Vaccine compositions and methods for the treatment and prevention of urinary tract infections Feb 15, 2022 Issued
Array ( [id] => 17625672 [patent_doc_number] => 20220160687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => PHARMACEUTICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/671157 [patent_app_country] => US [patent_app_date] => 2022-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28075 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17671157 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/671157
Pharmaceutical compositions Feb 13, 2022 Issued
Array ( [id] => 17712264 [patent_doc_number] => 11376243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-05 [patent_title] => Pharmaceutical compositions [patent_app_type] => utility [patent_app_number] => 17/671207 [patent_app_country] => US [patent_app_date] => 2022-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 28111 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17671207 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/671207
Pharmaceutical compositions Feb 13, 2022 Issued
Array ( [id] => 19359363 [patent_doc_number] => 20240261397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => IMMUNE PREPARATION, COMPOSITION COMPRISING IMMUNE PREPARATION AND USE THEREOF, AND PREPARATION METHOD [patent_app_type] => utility [patent_app_number] => 18/284812 [patent_app_country] => US [patent_app_date] => 2022-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7963 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284812 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/284812
IMMUNE PREPARATION, COMPOSITION COMPRISING IMMUNE PREPARATION AND USE THEREOF, AND PREPARATION METHOD Jan 26, 2022 Pending
Array ( [id] => 19584962 [patent_doc_number] => 20240382519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => MONOVALENT COPPER/PORPHYRIDIUM SP. POLYSACCHARIDE COMPLEXES, RELATED PRODUCTS AND METHODS OF PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/273467 [patent_app_country] => US [patent_app_date] => 2022-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11363 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273467 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/273467
MONOVALENT COPPER/PORPHYRIDIUM SP. POLYSACCHARIDE COMPLEXES, RELATED PRODUCTS AND METHODS OF PREPARATION THEREOF Jan 3, 2022 Abandoned
Array ( [id] => 19001985 [patent_doc_number] => 20240066056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => Formulations of a Prophylactic Nasal Spray and Methods of Use and Manufacture Thereof [patent_app_type] => utility [patent_app_number] => 18/260222 [patent_app_country] => US [patent_app_date] => 2022-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3784 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260222 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/260222
Formulations of a Prophylactic Nasal Spray and Methods of Use and Manufacture Thereof Jan 2, 2022 Pending
Array ( [id] => 18953766 [patent_doc_number] => 20240042093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => IN SITU SOLIDIFYING INJECTABLE COMPOSITIONS WITH TRANSIENT CONTRAST AGENTS AND METHODS OF MAKING AND USING THEREOF [patent_app_type] => utility [patent_app_number] => 18/268786 [patent_app_country] => US [patent_app_date] => 2021-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22909 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -70 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18268786 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/268786
IN SITU SOLIDIFYING INJECTABLE COMPOSITIONS WITH TRANSIENT CONTRAST AGENTS AND METHODS OF MAKING AND USING THEREOF Dec 21, 2021 Pending
Array ( [id] => 19119990 [patent_doc_number] => 11963951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-23 [patent_title] => Pharmaceutical compositions [patent_app_type] => utility [patent_app_number] => 17/552768 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 28084 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552768 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/552768
Pharmaceutical compositions Dec 15, 2021 Issued
Array ( [id] => 19032317 [patent_doc_number] => 20240082132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => STABILIZATION OF THIOPYRIDINONE COMPOUND AND YELLOWING REDUCTION OF COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 18/267333 [patent_app_country] => US [patent_app_date] => 2021-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267333 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/267333
STABILIZATION OF THIOPYRIDINONE COMPOUND AND YELLOWING REDUCTION OF COMPOSITION COMPRISING SAME Dec 9, 2021 Pending
Array ( [id] => 18921224 [patent_doc_number] => 20240024228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => Apremilast Ophthalmic Compositions [patent_app_type] => utility [patent_app_number] => 18/256733 [patent_app_country] => US [patent_app_date] => 2021-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6105 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256733 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/256733
Apremilast Ophthalmic Compositions Dec 7, 2021 Pending
Array ( [id] => 18806749 [patent_doc_number] => 20230381080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => USE OF PARTICULAR AMINO ACIDS AS A PRETREATMENT FOR A PROCESS FOR DYEING OR BLEACHING KERATIN FIBRES [patent_app_type] => utility [patent_app_number] => 18/265749 [patent_app_country] => US [patent_app_date] => 2021-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12001 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265749 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265749
USE OF PARTICULAR AMINO ACIDS AS A PRETREATMENT FOR A PROCESS FOR DYEING OR BLEACHING KERATIN FIBRES Dec 2, 2021 Pending
Array ( [id] => 18738059 [patent_doc_number] => 20230346971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => METHOD FOR TREATING TUMOURS BY CAPTURING COPPER AND/OR IRON [patent_app_type] => utility [patent_app_number] => 18/253694 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253694 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/253694
METHOD FOR TREATING TUMOURS BY CAPTURING COPPER AND/OR IRON Nov 18, 2021 Pending
Array ( [id] => 18893663 [patent_doc_number] => 20240009148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => Cystamine Formulations and Uses Thereof [patent_app_type] => utility [patent_app_number] => 18/252873 [patent_app_country] => US [patent_app_date] => 2021-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5305 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252873 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/252873
Cystamine Formulations and Uses Thereof Nov 17, 2021 Pending
Array ( [id] => 17458592 [patent_doc_number] => 20220071896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => NASAL DRUG PRODUCTS AND METHODS OF THEIR USE [patent_app_type] => utility [patent_app_number] => 17/528877 [patent_app_country] => US [patent_app_date] => 2021-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29752 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528877 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/528877
NASAL DRUG PRODUCTS AND METHODS OF THEIR USE Nov 16, 2021 Abandoned
Array ( [id] => 20848731 [patent_doc_number] => 12685748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-21 [patent_title] => Nanozyme compositions and methods of treatment [patent_app_type] => utility [patent_app_number] => 18/037271 [patent_app_country] => US [patent_app_date] => 2021-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 51 [patent_no_of_words] => 6540 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037271 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/037271
NANOZYME COMPOSITIONS AND METHODS OF TREATMENT Nov 15, 2021 Issued
Array ( [id] => 18986270 [patent_doc_number] => 20240058239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => FRAGRANCE COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/255931 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255931 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/255931
FRAGRANCE COMPOSITION Nov 11, 2021 Issued
Array ( [id] => 18877460 [patent_doc_number] => 20240000829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/250121 [patent_app_country] => US [patent_app_date] => 2021-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11254 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250121 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/250121
COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION Nov 8, 2021 Pending
Array ( [id] => 18842521 [patent_doc_number] => 20230404925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => JAK INHIBITORS HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTION [patent_app_type] => utility [patent_app_number] => 18/249869 [patent_app_country] => US [patent_app_date] => 2021-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11501 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249869 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/249869
JAK INHIBITORS HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTION Oct 24, 2021 Pending
Array ( [id] => 17383884 [patent_doc_number] => 20220031736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => USE OF ANIONIC CLAY IN PREPARING LEAD-REMOVING MEDICINE [patent_app_type] => utility [patent_app_number] => 17/502105 [patent_app_country] => US [patent_app_date] => 2021-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10642 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502105 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/502105
USE OF ANIONIC CLAY IN PREPARING LEAD-REMOVING MEDICINE Oct 14, 2021 Abandoned
Array ( [id] => 20958706 [patent_doc_number] => 12729131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-09-08 [patent_title] => Pigment comprising particles each containing calcium-titanium composite oxide as main component, method for producing same, and use of same [patent_app_type] => utility [patent_app_number] => 18/254946 [patent_app_country] => US [patent_app_date] => 2021-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10478 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254946 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/254946
Pigment Comprising Particles Each Containing Calcium-Titanium Composite Oxide As Main Component, Method For Producing Same, And Use Of Same Oct 14, 2021 Pending
Menu